Placental Findings in Pregnancies Complicated by Maternal Cardiovascular Disease
Fred M Wu,Bradley J Quade,Chrystalle Katte Carreon,Zoë J Schefter,Abigail Moses,Cara L Lachtrupp,John C Markley,Kimberlee Gauvreau,Anne Marie Valente,Katherine E Economy,STORCC Investigators,Shivani R Aggarwal,Nael Aldweib,Laith Alshawabkeh,Nancy Barker,Yonatan Buber,Jean Marie Carabuena,Matthew Carazo,Emily Dollar,Sheila Drakeley,Valeria Duarte,Sarah Rae Easter,Gabriele Egidy Assenza,Julia Graf,Michelle Gurvitz,Daniel Halpern,Amy Harmon,Kelsey Hickey,Jenna Hynes,Caitlyn Joyce,William P Knapp,Michael Landzberg,Roisin Morgan,Mary Mullen,Alexander Opotowsky,Sara Partington,Dorothy Pearson,Saraubh Rajpal,Carla P Rodriguez-Monserrate,Carrie Rouse,Keri Shafer,Michael N Singh,Ada C Stefanescu Schmidt,Allison L Tsao,Shailendra Upadhyay
DOI: https://doi.org/10.1016/j.jacadv.2022.100008
2022-03-16
Abstract:Background: The incidence of pregnancy in women with cardiovascular disease (CVD) has increased, yet little is known about placental pathology in these women. Objectives: The objectives of this study were to describe placental pathology in pregnancies complicated by maternal CVD and to compare findings among categories of maternal CVD. Methods: A retrospective, single-center study was conducted. Pathology reports for 264 placentas from pregnancies complicated by maternal CVD were reviewed for prespecified pathologic findings which were then compared against maternal characteristics. Results: Placentas were from pregnancies associated with maternal congenital heart disease (n = 171), arrhythmia (n = 43), cardiomyopathy (n = 20), connective tissue disease (n = 20), and valvular heart disease (n = 10). Median maternal age at delivery was 32 years (range: 19-49). Median gestational age at delivery was 39 weeks (range: 25-41). Placental pathology was identified in 75% (199/264) of placentas. Anatomic pathology, primarily small placenta by weight, was present in 45% (119/264) of placentas. Vascular pathology, primarily maternal vascular malperfusion or fetal vascular malperfusion, was seen in 41% (107/264) of placentas. Acute chorioamnionitis and villitis of unknown etiology (VUE) were seen in 23% (61/264) and 11% (28/264) of placentas, respectively. Prevalence of VUE differed across CVD categories (P = 0.008) and was most common in maternal congenital heart disease; there were no differences in anatomic, infectious, and vascular pathologies across CVD categories. Conclusions: Pregnancies among women with CVD commonly demonstrate abnormal placental findings, especially anatomic and vascular pathology. Prevalence of VUE differed across CVD categories. Otherwise, the incidence of specific pathology findings did not differ based on maternal characteristics.